Ambryon Biosciences

pMD2.G

Lentiviral envelope plasmid expressing the vesicular stomatitis virus G glycoprotein (VSV-G, Indiana strain): a CMV enhancer and promoter with an intron drives the VSV-G coding sequence, followed by a human β-globin polyadenylation signal. Deposited by Didier Trono (EPFL) as Addgene #12259, listed as a Trono lab envelope plasmid; it supplies the pseudotyping envelope in trans to a transfer vector and a packaging plasmid.

Characteristics

5,822 bp circular plasmid with ampicillin resistance in bacteria. The file annotates the CMV enhancer and promoter, a 476 bp β-globin intron (described as an internally truncated human β-globin intron), the VSV-G coding sequence (1,536 bp, 511 residues), a 395 bp human β-globin poly(A) signal, a pUC-type origin of replication, and AmpR with its promoter. The CMV enhancer, promoter and intron match the library's cmv-intron part exactly (1,242 bp, spanning the origin of the circular numbering). It annotates no long terminal repeats or packaging signal, so it is not itself packageable and cannot be transferred into target cells. Addgene lists the plasmid as unpublished, part of the Trono Lab Packaging and Envelope Plasmids, with no describing paper.

Applications

Supplying the VSV-G envelope glycoprotein in trans to pseudotype lentiviral particles, by co-transfection of producer cells such as HEK293T with a lentiviral transfer vector and a packaging plasmid. Citing papers used it as the VSV-G envelope plasmid with psPAX2 (Addgene #12260) in HEK293-type producer cells: lentiCRISPR v2 (Addgene #52961) at a 8:4:1 transfer:psPAX2:pMD2.G ratio in HEK293T/17 cells with polyethylenimine, medium changed 12 h after transfection and virus harvested after a further 48 h, then ultracentrifuged through a sucrose cushion (10.1016/j.cell.2016.09.031); a pSB700 sgRNA plasmid at a 4:3:1 ratio in 293T cells, with supernatant collected 48-72 h after transfection and concentrated by PEG precipitation, to deliver 30 gRNAs against NEUROD1 or NGN2 to human iPS cells expressing dCas9-AD (10.1038/nmeth.3312); lenti-Cas9 (Addgene #52962) and lentiGuide-Puro (Addgene #52963) with Fugene6 in HEK293T cells, to make Cas9 and ACE2 or B4GALT7 sgRNA knockout lines from A549 and A375 cells (10.1016/j.cell.2020.09.033); and pSLIK-hygro, pINDUCER20 and pLKO.1-puro at a 0.5:0.25:0.25 ratio in HEK293FT cells with Lipofectamine 3000, with supernatant collected 48 h after transfection (10.1038/s41586-020-2229-5). A further protocol paper lists it among its reagents (10.1038/nprot.2017.016).

Payload10 features

in a 5,822 bp deposit · 5 features outside the design

01000200030004000pMD2.GPlasmid DNA · 45% GCCMV promoter · promoter · 571–774 · 204 bpCMV promoterbeta-globin intron · intron · 908–1,383 · 476 bpbeta-globin intronVSV-G · CDS · 1,458–2,993 · 1,536 bpVSV-Gbeta-globin poly(A) · polyA signal · 3,194–3,588 · 395 bpbeta-globin poly(…CMV enhancer · enhancer · 191–570 · 380 bpCMV enhancerCMV enhancer, promoter and intron · promoter · 191–1,432 · 1,242 bpCMV enhancer, pro…01000200030004000pMD2.GPlasmid DNA · 45% GCCMV promoter · promoter · 571–774 · 204 bpCMV promoterbeta-globin intron · intron · 908–1,383 · 476 bpbeta-globin intronVSV-G · CDS · 1,458–2,993 · 1,536 bpVSV-Gbeta-globin poly(A) · polyA signal · 3,194–3,588 · 395 bpbeta-globin poly(A)CMV enhancer · enhancer · 191–570 · 380 bpCMV enhancerCMV enhancer, promoter and intron · promoter · 191–1,432 · 1,242 bpCMV enhancer, promoter…05001000150020002500300035004000pMD2.GPlasmid DNA · 45% GCCMV promoter · promoter · 571–774 · 204 bpCMV promoterbeta-globin intron · intron · 908–1,383 · 476 bpbeta-globin intronVSV-G · CDS · 1,458–2,993 · 1,536 bpVSV-Gbeta-globin poly(A) · polyA signal · 3,194–3,588 · 395 bpbeta-globin poly(A)CMV enhancer · enhancer · 191–570 · 380 bpCMV enhancerCMV enhancer, promoter and intron · promoter · 191–1,432 · 1,242 bpCMV enhancer, promoter and intr…

Sequence4,097 bp

Sign in to view the full sequence.

Sign in

Identifiers & revision